Northeast Cardiology Associates

Bangor, Maine 04401

0 studies enrolling now · 12 studies all time

What they study most

Angina Pectoris, Atherosclerotic Cardiovascular Disease, Atrial Fibrillation, Chronic Total Occlusion of Coronary Artery, Congestive Heart Failure, Coronary Artery Disease, Coronary Artery Stenosis, Coronary Disease, Coronary Restenosis, Heart Failure, Myocardial Ischemia, Paroxysmal Atrial Fibrillation

Studies at this site

• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early
• Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease — Running, not enrolling
• XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort — Completed
• FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMT — Completed
• Quadripolar Pacing Post Approval Study — Completed
• The Dual Antiplatelet Therapy Study (DAPT Study) — Completed
• Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI) — Completed
• Study of HD Mesh Ablation System for Treatment of Paroxysmal Atrial Fibrillation — Stopped early
• EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan — Completed
• TAXUS ARRIVE: TAXUS Peri-Approval Registry: A Multi-Center Safety Surveillance Program — Completed
• A Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart Attack — Stopped early